baber/WOPTO huggingface dataset:
Patent DK-0562102-T3 (DK)
Inventor: GOURLIA JEAN-PAUL
IPC: B01D69/10
Filed: 1992-10-08
Granted: 1995-08-28
Abstract: PCT No. PCT/FR92/00933 Sec. 371 Date Jun. 10, 1993 Sec. 102(e) Date Jun. 10, 1993 PCT Filed Oct. 8, 1992 PCT Pub. No. WO93/07433 PCT Pub. Date Apr. 15, 1993The invention relates to a method for improving heat and mass transfers to and/or through a wall, and if need be, to such a method applied to a permeable wall. The invention also concerns a wall and conductive material pair having improved heat and mass transfer characteristics. The method of the invention is useful for all techniques requiring both heat transfer and flow of gaseous phase to or through a wall.
Patent DK-0594001-T3 (DK)
Inventor: SHUTSKE GREGORY
IPC: A61P25/24
Filed: 1993-10-08
Granted: 2000-10-30
Abstract: The invention relates to compounds of the frmula <CHEM>  wherein     Ar is <CHEM>  or pyridyl;     R1 is H,-(CH2)pNR2R3, <CHEM>     R2 is hydrogen or loweralkyl;     R3 is hydrogen or loweralkyl;     R4 is hydrogen or loweralkyl; X and Y are independently halogen, trifluoromethyl, nitro, loweralkyl, loweralkoxy or hydroxy;     n is 0, 1, 2 or 3;     m is 0, 1 or 2;     p and q are independently 2, 3 or 4; or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof. This invention also relates to a process for making the compounds and to pharmaceutical compositions, and to their use as serotonin reuptake inhibitors.
Patent DK-0620857-T3 (DK)
Inventor: CASY GUY
IPC: C07D307/33
Filed: 1992-12-23
Granted: 2000-10-09
Abstract: PCT No. PCT/GB92/02396 Sec. 371 Date Aug. 26, 1994 Sec. 102(e) Date Aug. 26, 1994 PCT Filed Dec. 23, 1992 PCT Pub. No. WO93/13215 PCT Pub. Date Jul. 8, 1993A process for the production of a homochiral 2-hydroxy carboxylic acid or salt thereof corresponding to general formula (I), wherein R represents one of formulae (II), (III), (IV), (V), wherein R' represents straight- or branched-chain alkyl or phenyl optionally para-substituted with methyl, methoxy, nitro or amino; and R'' represents hydrogen, halogen or phenyl optionally para-substituted with methyl, methoxy, nitro or amino; and M represents hydrogen or a salt-forming moiety; characterized in that it comprises reducing a corresponding 2-keto carboxylic acid or salt thereof using a (R)- or (S)-2-oxo carboxylic acid dehydrogenase, inter alia, is disclosed.
Patent DK-0625186-T3 (DK)
Inventor: WONG ARTHUR
IPC: C11D17/04
Filed: 1993-01-27
Granted: 1997-04-14
Abstract: Disclosed are abrasive wiping articles, e.g., nonwoven, preferably paper towels, which comprise an absorbant nonwoven substrate having printed thereon a cured scrubbing bead mixture which comprises a) certain carboxylated, ionically-charged polymeric abrasive particles, b) a carboxyl group-containing polymeric adhesive material, and c) an amino-epichlorohydrin, e.g., Kymene TM , cross-linking agent. The polymeric abrasive particles range in size from about 20 to 400 microns and have a Knoop hardness of from about 4 to 25. The polymeric adhesive material, upon curing, has a Knoop hardness of from about 0.5 to 17. Preferred wiping articles of the foregoing type have a pattern of the scrubbing bead mixture printed onto from about 20% to 70% of the surface area of a paper substrate with the abrasive particles affixed to the substrate in such a manner that their exposed portion extends for a distance of from about 40 to 300 microns above the surface of the paper substrate. Wiping articles of this type are especially useful for removing soil and stain from hard surfaces with the polymeric scrubbing particles thereon being especially resistant to removal during use. Also disclosed is a process for preparing abrasive wiping articles as hereinbefore described. Such a process involves printing a pattern of the scrubbing bead mixture onto the paper substrate, drying the printed substrate and then curing the solid components of the scrubbing bead mixture to affix the abrasive scrubbing particles to the substrate. Curing of the particular scrubbing bead mixture employed can take place at room temperature.
Patent DK-0725939-T3 (DK)
Inventor: SPITZER MARK B
IPC: G02B27/00
Filed: 1993-03-12
Granted: 1999-11-15
Abstract: A method of forming a high resolution liquid crystal display device characterised by: forming an active matrix array with a single crystal silicon material, the display including an array pixel circuits and an array of pixel electrodes, a plurality of column address lines connected to a column driver circuit (20A,20B) and a plurality of row address lines connected to a row driver circuit (18A,18B) such that the display has a pixel density of at least 400 lines per centimetre; positioning a layer of liquid crystal material (19) adjacent to the active matrix array; optically coupling a light source to the active matrix array such that the images can be formed; and optically coupling a lens (1620) to the liquid crystal material to magnify an image on the display. <IMAGE>
Patent DK-0653122-T3 (DK)
Inventor: ZIERHUT HERMANN
IPC: H03K17/62
Filed: 1993-07-08
Granted: 1997-03-17
Abstract: PCT No. PCT/DE93/00605 Sec. 371 Date Jan. 17, 1995 Sec. 102(e) Date Jan. 17, 1995 PCT Filed Jul. 8, 1993 PCT Pub. No. WO94/03975 PCT Pub. Date Feb. 17, 1994.A drive circuit for triggering a symmetrical bipolar transistor, the drive circuit having a balanced circuit connected to two operating electrodes of the symmetrical bipolar transistor. The balanced circuit includes two parts connected by their bases. Collectors of the two parts of the balanced circuit act on inverse balanced circuits which control a switching device which in turn controls the triggering of the symmetrical bipolar transistor.
Patent DK-0662812-T3 (DK)
Inventor: HINTZ CLEAR SANDRA
IPC: A61F13/494
Filed: 1993-09-20
Granted: 1999-09-27
Abstract: Absorbent articles such as disposable diapers, incontinent briefs, diaper holders, training pants and the like, that have an elastic leg feature that provides dynamic fit around the leg of the wearer. Such absorbent articles comprise a liquid previous topsheet; a liquid impervious backsheet; an absorbent core disposed between the topsheet and the backsheet; and an elastic leg feature comprising an elasticized leg cuff and elasticized thigh panels. The elasticized leg cuff is positioned in at least the center leg zone of the elastic leg feature, and comprises one or more elastic members operatively associated in an elastically contractible condition so that the leg cuff is elastically contractible in generally the longitudinal direction. The elasticized thigh panels comprise a stretch laminate that is mechanically stretched so that the elasticized thigh panel is capable of expanding beyond the original planar state of the absorbent article in at least one direction at an angle from the longitudinal direction.
Patent DK-0612880-T3 (DK)
Inventor: MCBRIDE DANIEL TAYLOR
IPC: D06M101/16
Filed: 1994-02-24
Granted: 1999-06-21
Abstract: A process for protecting a dyed textile fiber from decolorization caused by exposure to bleach, and improving colorfastness is provided by applying an aqueous solution of non-volatile, polymeric salt forming monomers, such as hexamethylenediamine and adipic acid, to the textile fiber followed by drying the fiber to polymerize the monomers and form a non-volatile, polymeric salt film thereon. The process is especially suitable for treating dyed polyamide fiber used in floor covering products.
Patent DK-0699759-T3 (DK)
Inventor: SUGIMOTO MASAKAZU CENTRAL RES
IPC: C12P13/08
Filed: 1993-12-14
Granted: 2003-09-15
Abstract: A transformant with an increased rate of L-lysine production and secretion is obtained by introducing into a corynebacterium a recombinant DNA that can be replicated in a corynebacterium and contains either a DNA fragment originating in a corynebacterium and coding for an aspartokinase  alpha -subunit protein whereby a synergistic feedback inhibition by L-lysine and L-threonine is released or a DNA fragment originating in a corynebacterium and coding for an aspartokinase  beta -subunit protein whereby a synergistic feedback inhibition by L-lysine and L-threonine is released. The obtained transformant is cultured in a suitable medium and the formed L-lysine is separated. <MATH>
Patent DK-0691958-T3 (DK)
Inventor: MURRAY ROBERT JOHN
IPC: A61P25/00
Filed: 1994-04-05
Granted: 1997-12-08
Abstract: (S)- alpha -phenyl-2-pyridineethanamine benzoate is useful in the treatment of neurodegenerative disorders. It is an anticonvulsant and a neuroprotective agent.
Patent DK-0688006-T3 (DK)
Inventor: FERNANDEZ-KIRCHBERGER PAUL
IPC: B42D15/10
Filed: 1995-04-21
Granted: 1997-03-10
Abstract: Sheets of label carrying paper are produced for use in printers. The labels (15) are formed from sheet material and are separated from each other by cutting lines (16,18,22). The labels ar secured to a carrier or backing sheet (32) by lines of adhesive (40). The cutting of separating lines are formed by passing sheet material between rollers have cutting blades. Following rollers press the labels onto the backing sheet. The labels may be produced with square or radiused cover.
Patent DK-0709093-T3 (DK)
Inventor: BODICK NEIL CLAYTON
IPC: A61K31/55
Filed: 1995-10-30
Granted: 2000-07-10
Abstract: The present invention provides the use of a compound <CHEM>  wherein  X is oxygen or sulphur; R is hydrogen, amino, halogen, -CHO, -NO2, -OR<4>, -SR<4>, -SOR<4>, -SO2R<4>, C3-7-cycloalkyl, C4-8-(cycloalkylalkyl), -Z-C3-7-cycloalkyl, and -Z-C4-8-(cycloalkylalkyl) wherein R<4> is straight or branched C1-15-alkyl, straight or branched C2-15-alkenyl, straight or branched C2-15-alkynyl, each of which is optionally substituted with one or more halogens, -CF3, -CN, phenyl or phenoxy wherein phenyl or phenoxy is optionally substituted with halogen, -CN, C1-4-alkyl, C1-4-alkoxy, -OCF3, -CONH2 or -CSNH2; or R is phenyl or benzyloxycarbonyl, each of which is optionally substituted with halogen, -CN, C1-4-alkyl, C1-4-alkoxy, -OCF3, -CONH2 or -CSNH2; or R is -OR<5>Y, -SR<5>Y, -OR<5>ZY, -SR<5>ZY, -O-R<4>-Z-R<5> or -S-R<4>-Z-R<5> wherein Z is oxygen or sulphur, R5 is straight or branched C1-15-alkynyl, and Y is a 5 or 6 membered heterocyclic group containing one to four N, O or S atom(s) or a combination thereof, which heterocyclic group is optionally substituted at carbon or nitrogen atom(s) with straight or branched C1-6-alkyl, phenyl or benzyl, or which heterocyclic group is optionally fused with a phenyl group; and G is selected from one of the following azabicyclic rings <CHEM> wherein the thiadiazole or oxadiazole ring can be attached at any carbon atom of the azabicyclic ring; R<1> and R<2> may be present at any position, including the point of attachment of the thiadiazole or oxadiazole ring, and independently are hydrogen, straight or branched C1-5-alkyl, straight or branched C2-5 alkenyl, straight or branched C2-5-alkynyl, straight or branched C1-10-alkoxy, straight or branched C1-5-alkyl substituted with -OH, OR<4>, halogen, -NH2 or carboxy; R<3> is H, straight or branched C1-5-alkyl, straight or branched C2-5-alkenyl or straight or branched C2-5-alkynyl; n is 0, 1 or 2; m is 0, 1 or 2; p is 0, 1 or 2; q is 1 or 2; and --- is a single or double bond; or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of anxiety.
Patent DK-0709018-T3 (DK)
Inventor: NEUERBURG HORST
IPC: A01D75/20
Filed: 1995-10-26
Granted: 2001-07-23
Abstract: The implement has a coupling system (3) for hitching to a tractor, a cutter unit (2) which is connected directly or indirectly to the coupling system via an articulated joint which allows the implement to occupy two different positions, cutting tools (12) connected to a drive system (13,14,15) and a guard (18). The implement incorporates a stop (33) which prevents a moving section (23) of the guard from being moved into its non-operational position while the cutting mechanism is n its working position. The stop (33) is set automatically by means of an actuator (35) when the cutting mechanism is moved into its non-operating position, allowing access to the cutters.
Patent DK-0737277-T3 (DK)
Inventor: DELLMANN TORSTEN
IPC: F16D65/12
Filed: 1995-01-07
Granted: 1998-01-05
Abstract: An axle or wheel brake disk for rail vehicles is designed as a monobloc disk or as a disk formed by a hub (2) or segments and by a friction ring (1), preferably provided with inner ventilation and having hard ceramic particles distributed in an aluminium alloy matrix. The invention consists in that at least the friction ring (1), preferably also the cooling ribs (3) linked thereto and/or also the hub (2) or segments are made of a sub-eutectic AlSi base alloy reinforced by hard ceramic particles.
Patent DK-0792433-T3 (DK)
Inventor: LETZEL HELMUT
IPC: F24D19/08
Filed: 1995-12-05
Granted: 1999-09-20
Abstract: A valve is disclosed for heating, hot water or cooling systems having a connection pipe (11, 12) that leads to the train of pipes and to the consumer. A screw socket (13) receives a first closure piece (4) arranged in a hollow valve spindle (3). The first closure piece (4) forms throttle-like flow pre-setting means with a valve seat (14) in the housing (1). A second, double acting valve closure piece (5) that may be actuated from the outside against the pressure of a spring (6) by a regulator or the like is arranged in the hollow valve spindle (3) and slides in the valve spindle (3) against a corresponding valve seat (33). The hollow valve spindle (3) has two sections (3a, 3b) fitted into each other and a flat gasket (33) is sealingly arranged between both sections. The top end (51) of the second closure piece (5) acts against the inwardly projecting part of the flat gasket (33).
Patent DK-0817614-T3 (DK)
Inventor: COLLINS DAVID
IPC: A61K47/48
Filed: 1996-03-28
Granted: 2002-10-07
Abstract: The invention relates to stable compositions of proteins and related methods wherein a protein capable of transitioning into the molten globular state is contacted with a negatively charged lipid vesicle, thereby stabilizing the protein against thermally-induced aggregation, denaturation, and loss of activity. The protein:phospholipid complex directly stabilizes the secondary and tertiary structure of the protein, and the compositions are useful in high temperature formulations and in novel delivery vehicles.
Patent DK-0854826-T3 (DK)
Inventor: PETER JAN WILLEM KROUWEL
IPC: B65D83/04
Filed: 1996-08-22
Granted: 2001-03-05
Abstract: PCT No. PCT/NL96/00332 Sec. 371 Date Jun. 3, 1998 Sec. 102(e) Date Jun. 3, 1998 PCT Filed Aug. 22, 1996 PCT Pub. No. WO97/08078 PCT Pub. Date Mar. 6, 1997An apparatus for dispensing pills from a blister pack in which cavities containing pills are distributed, comprises a lower part for supporting the pack in a ring-shape and an upper part fitting onto the lower part and surrounding the blister pack together with the lower part. The lower part and/or upper part includes at least a passage opening with which a pill to be dispensed can be aligned. A push out element can be positioned in line with the various pills in the blister pack and the passage opening and is operable for pushing out the pill to be dispensed through the passage opening. The lower and upper parts are substantially ring-shaped and the push out element is positioned on the inner side of the ring and is moveable outwardly for the push out action.
Patent DK-0854729-T3 (DK)
Inventor: LOWELL GEORGE H
IPC: A61K39/095
Filed: 1996-09-18
Granted: 2004-07-12
Abstract: A method for preparing multivalent proteosomeamphiphilic determinant vaccines suitable for parenteral or mucosal administration using diafiltration or ultrafiltration technology. The amphiplilic determinants include lipopolysaccharides from gram negative bacteria, e.g. S. flexneri, P. shigelloides and S. sonnei. Proteosomes are obtained from group B type 2b meningococci. The active proteosomeamphiphilic determinant complexes (noncovalently complexes) of the vaccine are formed using defiltration or ultrafiltration to remove the detergent. The use of diafiltration or ultrafiltration decreases processing time and the opportunity for contamination and further permits the use of ambient temperature and efficient scaleup. In addition, the process permits the reliable and continuous monitoring of the dialysate which enhances the efficiency of the entire process. The time of dialysis for production of a lot of vaccine is reduced from 710 days to less than 72 hours and usually less than 48 or 4 hours. The use of the process optimizes the presence of each antigenic component in the preparation of multivalent vaccines.
Patent DK-0929552-T3 (DK)
Inventor: KONOPA JERZY KAZIMIERZ
IPC: C07D471/04
Filed: 1997-09-10
Granted: 2002-07-22
Abstract: A process of preparing a compound of formula (I):wherein R1 and R2 are alkyl groups of 1 to 4 carbon atoms and n is from 2 to 5, comprises reacting a 1-chloro-7-(protected hydroxy)-4-nitroacridin-9(10H)-one of formula (IV-P):wherein A is a hydroxy-protecting group removable by reduction, with an omega-(dialkylamino)alkylamine of formulain which n, R1 and R2 are as defined above, to produce a 7-(protected hydroxy)4-nitro-1-[[omega-(dialkylamino)alkyl]amino]acridin-9(10H)-one (III-P), reducing the compound III-P at a temperature of from 15 to 50° C. with a hydrogen gas or with formate ions, in the presence of a palladium catalyst and formic acid, removing substantially all the residual palladium and heating the remaining reaction mixture to effect cyclization to the corresponding compound of formula (I). If desired, after removal of the palladium the intermediate 7-hydroxy-4-N-formyl-1-[[omega-(dialkylamino)alkyl]amino]acridin]-9(10H)-one can be isolated and subsequently cyclized by heating. Such compounds have anti-neoplastic activity.
Patent DK-0931092-T3 (DK)
Inventor: KEYT BRUCE A
IPC: A61K38/00
Filed: 1997-10-10
Granted: 2004-05-17
Abstract: The present invention involves the preparation of vascular endothelial growth factor (VEGF) antagonist molecules comprising variant VEGF polypeptides which are capable of binding to and occupying cell surface VEGF receptors without inducing a VEGF response, thereby antagonizing the biological activity of the native VEGF protein. Specifically, the variant VEGF polypeptides of the present invention comprise modifications of at least one cysteine residue in the native VEGF sequence, thereby inhibiting the ability of the variant polypeptide to dimerize through the formation of disulfide bonds. The present invention is further directed to methods for preparing such variant VEGF antagonists and to methods, compositions and assays utilizing such variants for producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from the native VEGF protein.
Patent DK-0919814-T3 (DK)
Inventor: THOMAS JEAN-LUC
IPC: G01P3/56
Filed: 1998-11-26
Granted: 2004-11-22
Abstract: Precise estimation of speed during the wheel slip phase is made by calculating mechanical equations of rotating parts to derive parameters of each wheel force applied to tracks, using model of vehicle from knowledge of its mass. Measurement is made of the wheel speed and the value of motor coupling or braking applied, when all the wheels slip on the running track. A calculation is made e.g. for module (A), from mechanical equations of the rotating parts and knowledge of the mechanical parameters of each wheel or group of linked wheels, in first period of time, of the force transmitted to the running track, from which by summation of the wheel assembly or groups of independent wheels, calculation is made of the total force transmitted to the running track module (B). An estimated value of the vehicles speed at any instant can then be calculated module (C), from the total force applied to the track by the mechanical model of the vehicle from a knowledge of its mass. The mass can be variable according to the vehicles load, it is then more precise to measure the suspension height of the pressure in the secondary suspension. The mass can be estimated by the module (D) from measure of the acceleration of the vehicle on flat track when wheel slip does not occur. Module (E) is used to calculate rolling resistance and module (F) is used to take into account any track slope.
Patent DK-0958157-T3 (DK)
Inventor: LUCAS FREDERICK GEORGE GRAHAM
IPC: B67D7/04
Filed: 1998-02-03
Granted: 2002-04-29
Abstract: A bulk fluid delivery system comprising a plurality of storage volumes (1a to 1b) each connected to the inlet of a pump 4 via a selector valve 3 and a duct, a metering means 5 to measure the output of the pump, and a delivery hose 7 connected to the outlet of the pump and having a delivery nozzle 8 at its end remote from the pump, the system further comprising a return pipe 10 extending from an inlet nozzle 11 to communicate selectively with one of the storage volumes, the delivery nozzle being connectable to the inlet nozzle to purge the delivery hose of one fluid from a first storage volume prior to dispensing a second fluid from a second storage volume. In a preferred embodiment the fluid delivered is fuel and the apparatus is mounted on a road tanker capable of delivering a number of different bulk fuels as required.
Patent DK-0966768-T3 (DK)
Inventor: PAULING HANS JUERGEN
IPC: H01M50/463
Filed: 1998-02-25
Granted: 2002-04-02
Abstract: The invention relates to a rechargeable battery system with a plurality of electrodes in an electrolyte space filled with electrolyte, which can be tapped with the aid of an electrical tap. At least one of the electrodes is constructed as a substantially insoluble electrode of the second type. Said electrode also has a large-pore and small-pore separator arrangement or an electrochemically active coating provided with a surface profile, through which it is possible to reduce at least the structural and/or shape changes of the electrode during cyclic charging and discharging linked with the sinking of mechanically unstable discharge products.
Patent DK-0980374-T3 (DK)
Inventor: PASCAL YVES
IPC: C07D487/04
Filed: 1998-04-30
Granted: 2003-05-05
Abstract: The present invention presents compounds that inhibit phosphodiesterase 4 having Formula (I). The present invention also provides methods of using the compounds of Formula (I) to prevent or treat asthma, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disorders, pulmonary hypertension, liver injury, bone loss, septic shock, or multiple sclerosis, and to pharmaceutical compositions that contain the compounds of Formula (I).
Patent DK-1003458-T3 (DK)
Inventor: MILLS CHARLES OSWALD
IPC: A61K49/00
Filed: 1998-08-03
Granted: 2002-11-18
Abstract: A method for the determination of liver function, comprises the steps of: (i)introducing an effective amount of a coloured or fluorescent bile acid derivative intravenously into a patient, (ii)collecting samples of blood which has passed through the liver of the patient at timed intervals after step (i), and (iii)assessing the colour or fluorescence of bile acid derivative in each sample.
Patent DK-1025404-T3 (DK)
Inventor: DOOMERNIK CORNELIS
IPC: F25B49/02
Filed: 1998-10-23
Granted: 2002-08-19
Abstract: Method for operating a refrigeration system (20) by means of a refrigerant circuit, in which to condensate the refrigerant in said circuit a cooling water circuit is used, incorporating an evaporative condenser (6), evaporation losses from said condenser (6) being topped up with the aid of make-up water being supplied to the condenser (6) via a heat exchanger (21) with the aid of which the liquid refrigerant of the refrigeration circuit (20) is subcooled.
Patent DK-1042443-T3 (DK)
Inventor: BECKER NATHANIEL T
IPC: C11D11/00
Filed: 1998-12-21
Granted: 2007-03-05
Abstract: A granule having high stability and low dust is described. The granule includes a hydrated barrier material having moderate or high water activity. Also described are methods of producing the granules.